Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-05-17 13:03 Tx date 2022-05-13 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+16,096 vol |
33,633 | |
Filed 2021-12-28 11:53 Tx date 2021-12-22 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+17,537 vol |
17,537 | |
Filed 2021-12-28 11:52 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-08-21 22:50 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+10,000 vol $0.60 each |
67,730 | |
Filed 2019-05-25 14:52 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
57,730 | |
Filed 2019-05-24 12:13 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
||
Filed 2019-05-24 12:13 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
57,730 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
47,730 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
37,730 | |
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,714
+16,442 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,714
+16,442 vol $0.53 each |
36,681 | |
Filed 2018-03-16 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-02-07 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+32,884 vol |
||
Filed 2018-03-16 Tx date 2018-02-07 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+32,884 vol |
||
Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+32,884 vol |
32,884 | |
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
-32,884 vol |
||
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
-32,884 vol |
||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-17,428.52
-32,884 vol $0.53 each |
0 | |
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,714
+16,442 vol $0.53 each |
||
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,500 vol |
27,730 | |
Filed 2016-10-03 Tx date 2016-09-29 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,230 vol |
9,230 | |
Filed 2016-10-03 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-06 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,239 |